jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Review

Chemistry, Manufacturing and Control (CMC) Evaluations of ANDA Submission in the USA

Akshatha G1, Anoop Narayanan V1★, Sandeep D S1, Narayana Charyulu R1★ Corresponding author

  1. 1Department of Pharmaceutics, Nitte Gulabi Shetty Memorial (NGSM) Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Paneer, Mangalore, Karnataka, INDIA.

CORRESPONDENCE

Anoop Narayanan V

Department of Pharmaceutics, Nitte Gulabi Shetty Memorial (NGSM) Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Paneer, Mangalore, Karnataka, INDIA.

anoopvn84@gmail.com

Received: 15-12-2018; Revised: 06-02-2019; Accepted: 03-05-2019.

Volume 53, Issue 3 · pp. 414–420 · PUBLISHED 2019 · DOI: 10.5530/ijper.53.3.74

View on IJPER original site ↗

ABSTRACT

Background: The Abbreviated New Drug Application commonly referred as ANDA is an application that contains data submitted to US FDA for the review and prospective marketing authorization of generic drugs. The conduct of the reviewing of the application is done by the Division of Filing Review (DFR), Office of Regulatory Operations (ORO) in the Office of Generic Drugs (OGD). The format of ANDA: USFDA recommends the submission of ANDA applications as per ICH Common Technical Document (CTD) format. Module 3: Module 3 of CTD contains Chemistry, Manufacturing and Control (CMC) information including all the supporting details verifying that was summarised in section 2.3 which is the quality overall summary. Evaluation of ANDA: For the evaluation of an Abbreviated New Drug Application in the US, its Office of Generic Drugs (OGD) has developed a Question-based Review (QbR) for its CMC section which is mainly focussed on the critical quality attributes. Conclusion: The implementation of Questionbased Review programme is yielding good improvements in FDA’s division of Office of Generic Drugs (OGD), i.e., by advancing the review pattern of the ANDA CMC section without compromising quality and efficacy for the indication of the generic product.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    G, A., V, A. N., S, S. D., & R, N. C. (2019). Chemistry, Manufacturing and Control (CMC) Evaluations of ANDA Submission in the USA. Indian Journal of Pharmaceutical Education and Research, 53(3), 414–420. https://doi.org/10.5530/ijper.53.3.74